TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2735005
log Bayes Factor = 27.4757
Chromosome 6   position 29,808,464  (GRCh37) Explore rs2735005 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.000 0.000 1.000
L40.5 Arthropathic psoriasis
0.000 0.000 1.000
L40 Psoriasis
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.001 0.999
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.001 0.999
E10-E14 Diabetes mellitus
0.000 0.001 0.999
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.004 0.996
E70-E90 Metabolic disorders
0.000 0.006 0.994
E83 Disorders of mineral metabolism
0.000 0.006 0.994
E16 Other disorders of pancreatic internal secretion
0.000 0.007 0.993
E16.2 Hypoglycaemia, unspecified
0.000 0.008 0.992
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.011 0.989
E00-E07 Disorders of thyroid gland
0.000 0.012 0.988
E05.9 Thyrotoxicosis, unspecified
0.000 0.016 0.984
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.023 0.977
E10.9 Without complications
0.000 0.027 0.973
E10.3 With ophthalmic complications
0.000 0.048 0.952
E10.1 With ketoacidosis
0.000 0.050 0.950
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.075 0.925
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.083 0.917
E10.4 With neurological complications
0.000 0.114 0.886
E89.0 Postprocedural hypothyroidism
0.000 0.125 0.875
E80.4 Gilbert's syndrome
0.000 0.141 0.858
N40 Hyperplasia of prostate
0.835 0.165 0.000
L40.8 Other psoriasis
0.000 0.175 0.825
E10.6 With other specified complications
0.000 0.185 0.815
E85 Amyloidosis
0.000 0.191 0.809
E10.5 With peripheral circulatory complications
0.000 0.194 0.806
E10.0 With coma
0.000 0.198 0.802
E14 Unspecified diabetes mellitus
0.000 0.240 0.760
E10.2 With renal complications
0.000 0.240 0.760
E11 Non-insulin-dependent diabetes mellitus
0.000 0.245 0.755
E73 Lactose intolerance
0.000 0.258 0.742
L40.3 Pustulosis palmaris et plantaris
0.000 0.258 0.742
E11.3 With ophthalmic complications
0.000 0.267 0.733
E89.2 Postprocedural hypoparathyroidism
0.000 0.272 0.728
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.277 0.722
E79 Disorders of purine and pyrimidine metabolism
0.000 0.278 0.722
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.279 0.720
L40.2 Acrodermatitis continua
0.000 0.283 0.717
L40.1 Generalised pustular psoriasis
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.716
E12 Malnutrition-related diabetes mellitus
0.000 0.284 0.716
E15 Nondiabetic hypoglycaemic coma
0.000 0.286 0.714
E84 Cystic fibrosis
0.000 0.287 0.713
E77 Disorders of glycoprotein metabolism
0.000 0.287 0.713
E76 Disorders of glycosaminoglycan metabolism
0.000 0.287 0.713
E72 Other disorders of amino-acid metabolism
0.000 0.287 0.713
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.287 0.713
E70 Disorders of aromatic amino-acid metabolism
0.000 0.287 0.713
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.287 0.713
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.288 0.712
E83.8 Other disorders of mineral metabolism
0.000 0.288 0.712
E83.2 Disorders of zinc metabolism
0.000 0.288 0.712
E83.0 Disorders of copper metabolism
0.000 0.288 0.712
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.288 0.712
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.288 0.712
E16.4 Abnormal secretion of gastrin
0.000 0.288 0.712
E16.3 Increased secretion of glucagon
0.000 0.288 0.712
E74 Other disorders of carbohydrate metabolism
0.000 0.288 0.712
E80.2 Other porphyria
0.000 0.289 0.711
E14.3 With ophthalmic complications
0.000 0.290 0.710
E05.5 Thyroid crisis or storm
0.000 0.291 0.709
E05.4 Thyrotoxicosis factitia
0.000 0.291 0.709
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.291 0.709
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.291 0.709
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.291 0.708
E00 Congenital iodine-deficiency syndrome
0.000 0.291 0.708
E16.1 Other hypoglycaemia
0.000 0.294 0.706
E05.8 Other thyrotoxicosis
0.000 0.309 0.691
E80.1 Porphyria cutanea tarda
0.000 0.315 0.685
E89.4 Postprocedural ovarian failure
0.000 0.316 0.684
E10.8 With unspecified complications
0.000 0.319 0.680
E85.9 Amyloidosis, unspecified
0.000 0.329 0.671
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.337 0.663
E80.5 Crigler-Najjar syndrome
0.000 0.337 0.663
E80.3 Defects of catalase and peroxydase
0.000 0.337 0.663
E80.0 Hereditary erythropoietic porphyria
0.000 0.337 0.663
E80.6 Other disorders of bilirubin metabolism
0.000 0.340 0.660
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.342 0.658
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.342 0.658
E89.5 Postprocedural testicular hypofunction
0.000 0.342 0.658
E13 Other specified diabetes mellitus
0.000 0.345 0.655
L40.4 Guttate psoriasis
0.000 0.346 0.654
E85.4 Organ-limited amyloidosis
0.000 0.347 0.653
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.356 0.644
L40.0 Psoriasis vulgaris
0.000 0.369 0.631
E40-E46 Malnutrition
0.000 0.385 0.615
E11.5 With peripheral circulatory complications
0.000 0.385 0.615
E89.3 Postprocedural hypopituitarism
0.000 0.392 0.608
E07 Other disorders of thyroid
0.000 0.403 0.597
E03 Other hypothyroidism
0.000 0.407 0.593
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.409 0.590
E88 Other metabolic disorders
0.000 0.410 0.590
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.420 0.580
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.420 0.580
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.420 0.580
E14.6 With other specified complications
0.000 0.426 0.574
E89.1 Postprocedural hypoinsulinaemia
0.000 0.426 0.573
E11.1 With ketoacidosis
0.000 0.429 0.571
E85.3 Secondary systemic amyloidosis
0.000 0.433 0.567
E14.8 With unspecified complications
0.000 0.434 0.566
E14.5 With peripheral circulatory complications
0.000 0.435 0.565
E73.9 Lactose intolerance, unspecified
0.000 0.439 0.561
E11.8 With unspecified complications
0.000 0.442 0.558
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.445 0.555
E14.4 With neurological complications
0.000 0.449 0.551
E50-E64 Other nutritional deficiencies
0.000 0.450 0.550
E14.7 With multiple complications
0.000 0.455 0.545
E14.0 With coma
0.000 0.455 0.545
E11.7 With multiple complications
0.000 0.459 0.541
E73.8 Other lactose intolerance
0.000 0.468 0.532
E73.1 Secondary lactase deficiency
0.000 0.468 0.532
E73.0 Congenital lactase deficiency
0.000 0.468 0.532
E14.1 With ketoacidosis
0.000 0.469 0.531
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.473 0.527
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.482 0.518
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.482 0.518
E79.1 Lesch-Nyhan syndrome
0.000 0.482 0.518
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.489 0.511
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.489 0.511
E70.3 Albinism
0.000 0.489 0.511
E70.2 Disorders of tyrosine metabolism
0.000 0.489 0.511
E70.1 Other hyperphenylalaninaemias
0.000 0.489 0.511
E70.0 Classical phenylketonuria
0.000 0.489 0.511
E71.3 Disorders of fatty-acid metabolism
0.000 0.489 0.511
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.489 0.511
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.489 0.511
E71.0 Maple-syrup-urine disease
0.000 0.489 0.511
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.489 0.511
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.489 0.511
E72.5 Disorders of glycine metabolism
0.000 0.489 0.511
E72.4 Disorders of ornithine metabolism
0.000 0.489 0.511
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.489 0.511
E72.2 Disorders of urea cycle metabolism
0.000 0.489 0.511
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.489 0.511
E72.0 Disorders of amino-acid transport
0.000 0.489 0.511
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.489 0.511
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.489 0.511
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.489 0.511
E76.2 Other mucopolysaccharidoses
0.000 0.489 0.511
E76.1 Mucopolysaccharidosis, type II
0.000 0.489 0.511
E76.0 Mucopolysaccharidosis, type I
0.000 0.489 0.511
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.489 0.511
E77.8 Other disorders of glycoprotein metabolism
0.000 0.489 0.511
E77.1 Defects in glycoprotein degradation
0.000 0.489 0.511
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.489 0.511
E84.9 Cystic fibrosis, unspecified
0.000 0.489 0.511
E84.8 Cystic fibrosis with other manifestations
0.000 0.489 0.511
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.489 0.511
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.489 0.511
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.490 0.510
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.490 0.510
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.490 0.510
E74.2 Disorders of galactose metabolism
0.000 0.490 0.510
E74.1 Disorders of fructose metabolism
0.000 0.490 0.510
E74.0 Glycogen storage disease
0.000 0.490 0.510
E11.4 With neurological complications
0.000 0.490 0.510
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.491 0.509
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.492 0.508
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.492 0.508
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.492 0.508
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.492 0.508
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.492 0.508
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.492 0.508
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.492 0.508
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.492 0.508
E85.8 Other amyloidosis
0.000 0.494 0.505
E65-E68 Obesity and other hyperalimentation
0.000 0.519 0.481
E14.2 Withrenal complications
0.000 0.527 0.473
E11.0 With coma
0.000 0.528 0.472
E13.8 With unspecified complications
0.000 0.530 0.470
E13.7 With multiple complications
0.000 0.530 0.470
E13.6 With other specified complications
0.000 0.530 0.470
E13.5 With peripheral circulatory complications
0.000 0.530 0.470
E13.4 With neurological complications
0.000 0.530 0.470
E13.3 With ophthalmic complications
0.000 0.530 0.470
E13.2 With renal complications
0.000 0.530 0.470
E13.1 With ketoacidosis
0.000 0.530 0.470
E13.0 With coma
0.000 0.530 0.470
E75.6 Lipid storage disorder, unspecified
0.000 0.538 0.462
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.538 0.462
E75.3 Sphingolipidosis, unspecified
0.000 0.538 0.462
E75.2 Other sphingolipidosis
0.000 0.538 0.462
E75.1 Other gangliosidosis
0.000 0.538 0.462
E75.0 GM2 gangliosidosis
0.000 0.538 0.462
E83.3 Disorders of phosphorus metabolism
0.000 0.538 0.462
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.552 0.448
E03.8 Other specified hypothyroidism
0.000 0.558 0.441
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.559 0.441
E45 Retarded development following protein-energy malnutrition
0.000 0.559 0.441
E43 Unspecified severe protein-energy malnutrition
0.000 0.559 0.441
E42 Marasmic kwashiorkor
0.000 0.559 0.441
E41 Nutritional marasmus
0.000 0.559 0.441
E40 Kwashiorkor
0.000 0.559 0.441
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.571 0.428
E07.1 Dyshormogenetic goitre
0.000 0.571 0.428
E07.0 Hypersecretion of calcitonin
0.000 0.571 0.428
E03.5 Myxoedema coma
0.000 0.575 0.425
E03.4 Atrophy of thyroid (acquired)
0.000 0.575 0.425
E03.3 Postinfectious hypothyroidism
0.000 0.575 0.425
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.575 0.425
E03.9 Hypothyroidism, unspecified
0.000 0.581 0.419
K90 Intestinal malabsorption
0.000 0.583 0.417
E58 Dietary calcium deficiency
0.000 0.583 0.417
E03.1 Congenital hypothyroidism without goitre
0.000 0.584 0.415
E11.6 With other specified complications
0.000 0.587 0.412
E13.9 Without complications
0.000 0.592 0.408
E07.9 Disorder of thyroid, unspecified
0.000 0.598 0.402
E88.8 Other specified metabolic disorders
0.000 0.605 0.395
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.605 0.395
E63 Other nutritional deficiencies
0.000 0.605 0.395
E56 Other vitamin deficiencies
0.000 0.605 0.395
E50 Vitamin A deficiency
0.000 0.605 0.395
E60 Dietary zinc deficiency
0.000 0.605 0.395
E59 Dietary selenium deficiency
0.000 0.605 0.395
E54 Ascorbic acid deficiency
0.000 0.605 0.395
E52 Niacin deficiency [pellagra]
0.000 0.605 0.395
E51 Thiamine deficiency
0.000 0.606 0.394
E75.5 Other lipid storage disorders
0.000 0.607 0.393
E88.3 Tumour lysis syndrome
0.000 0.611 0.389
E88.9 Metabolic disorder, unspecified
0.000 0.613 0.387
E88.2 Lipomatosis, not elsewhere classified
0.000 0.615 0.385
E11.2 With renal complications
0.000 0.624 0.376
E53 Deficiency of other B group vitamins
0.000 0.625 0.375
E07.8 Other specified disorders of thyroid
0.000 0.644 0.355
E65 Localised adiposity
0.000 0.647 0.353
E61 Deficiency of other nutrient elements
0.000 0.650 0.350
E67 Other hyperalimentation
0.000 0.655 0.345
E68 Sequelae of hyperalimentation
0.000 0.655 0.345
K90.9 Intestinal malabsorption, unspecified
0.000 0.660 0.340
E46 Unspecified protein-energy malnutrition
0.000 0.660 0.340
E44.1 Mild protein-energy malnutrition
0.000 0.683 0.316
E44.0 Moderate protein-energy malnutrition
0.000 0.683 0.316
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.694 0.306
K90.3 Pancreatic steatorrhoea
0.000 0.701 0.299
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.701 0.299
K90.1 Tropical sprue
0.000 0.701 0.299
E55 Vitamin D deficiency
0.000 0.705 0.295
K90.8 Other intestinal malabsorption
0.000 0.708 0.292
E50.9 Vitamin A deficiency, unspecified
0.000 0.717 0.283
E50.8 Other manifestations of vitamin A deficiency
0.000 0.717 0.283
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.717 0.283
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.717 0.283
E50.5 Vitamin A deficiency with night blindness
0.000 0.717 0.283
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.717 0.283
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.717 0.283
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.717 0.283
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.717 0.283
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.717 0.283
E56.9 Vitamin deficiency, unspecified
0.000 0.717 0.283
E56.8 Deficiency of other vitamins
0.000 0.717 0.283
E56.1 Deficiency of vitamin K
0.000 0.717 0.283
E56.0 Deficiency of vitamin E
0.000 0.717 0.283
E63.9 Nutritional deficiency, unspecified
0.000 0.717 0.283
E63.8 Other specified nutritional deficiencies
0.000 0.717 0.283
E63.1 Imbalance of constituents of food intake
0.000 0.717 0.283
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.717 0.283
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.717 0.283
E64.8 Sequelae of other nutritional deficiencies
0.000 0.717 0.283
E64.3 Sequelae of rickets
0.000 0.717 0.283
E64.2 Sequelae of vitamin C deficiency
0.000 0.717 0.283
E64.1 Sequelae of vitamin A deficiency
0.000 0.717 0.283
E64.0 Sequelae of protein-energy malnutrition
0.000 0.717 0.283
E51.9 Thiamine deficiency, unspecified
0.000 0.718 0.282
E51.8 Other manifestations of thiamine deficiency
0.000 0.718 0.282
E51.1 Beriberi
0.000 0.718 0.282
E51.2 Wernicke's encephalopathy
0.000 0.719 0.281
E53.1 Pyridoxine deficiency
0.000 0.731 0.269
E53.0 Riboflavin deficiency
0.000 0.731 0.269
E53.8 Deficiency of other specified B group vitamins
0.000 0.734 0.266
E53.9 Vitamin B deficiency, unspecified
0.000 0.749 0.251
E61.9 Deficiency of nutrient element, unspecified
0.000 0.749 0.251
E61.8 Deficiency of other specified nutrient elements
0.000 0.749 0.251
E61.7 Deficiency of multiple nutrient elements
0.000 0.749 0.251
E61.6 Vanadium deficiency
0.000 0.749 0.251
E61.5 Molybdenum deficiency
0.000 0.749 0.251
E61.4 Chromium deficiency
0.000 0.749 0.251
E61.3 Manganese deficiency
0.000 0.749 0.251
E61.2 Magnesium deficiency
0.000 0.749 0.251
E61.0 Copper deficiency
0.000 0.749 0.251
E67.8 Other specified hyperalimentation
0.000 0.752 0.247
E67.3 Hypervitaminosis D
0.000 0.752 0.247
E67.2 Megavitamin-B6 syndrome
0.000 0.752 0.247
E67.1 Hypercarotenaemia
0.000 0.752 0.247
E67.0 Hypervitaminosis A
0.000 0.752 0.247
E06 Thyroiditis
0.001 0.758 0.241
E04 Other non-toxic goitre
0.000 0.763 0.237
L40-L45 Papulosquamous disorders
0.000 0.763 0.237
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.763 0.236
E83.4 Disorders of magnesium metabolism
0.000 0.770 0.230
E55.0 Rickets, active
0.000 0.788 0.211
E61.1 Iron deficiency
0.000 0.794 0.206
E06.4 Drug-induced thyroiditis
0.001 0.826 0.173
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.001 0.826 0.173
E06.0 Acute thyroiditis
0.001 0.826 0.173
E04.8 Other specified non-toxic goitre
0.000 0.830 0.170
L44 Other papulosquamous disorders
0.000 0.830 0.170
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.830 0.170
L42 Pityriasis rosea
0.000 0.831 0.169
E04.0 Non-toxic diffuse goitre
0.000 0.841 0.158
E83.5 Disorders of calcium metabolism
0.000 0.844 0.156
E04.1 Non-toxic single thyroid nodule
0.000 0.846 0.154
E06.1 Subacute thyroiditis
0.001 0.848 0.151
L41 Parapsoriasis
0.000 0.850 0.149
E06.5 Other chronic thyroiditis
0.001 0.852 0.147
L44.9 Papulosquamous disorder, unspecified
0.000 0.878 0.122
L44.8 Other specified papulosquamous disorders
0.000 0.878 0.122
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.878 0.122
L44.3 Lichen ruber moniliformis
0.000 0.878 0.122
L44.2 Lichen striatus
0.000 0.878 0.122
L44.1 Lichen nitidus
0.000 0.878 0.122
L44.0 Pityriasis rubra pilaris
0.000 0.878 0.122
E06.9 Thyroiditis, unspecified
0.001 0.886 0.113
L43 Lichen planus
0.000 0.886 0.114
E55.9 Vitamin D deficiency, unspecified
0.000 0.888 0.111
L41.9 Parapsoriasis, unspecified
0.000 0.892 0.107
L41.8 Other parapsoriasis
0.000 0.892 0.107
L41.5 Retiform parapsoriasis
0.000 0.892 0.107
L41.4 Large plaque parapsoriasis
0.000 0.892 0.107
L41.3 Small plaque parapsoriasis
0.000 0.892 0.107
L41.2 Lymphomatoid papulosis
0.000 0.892 0.107
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.892 0.107
E04.9 Non-toxic goitre, unspecified
0.000 0.902 0.098
E06.3 Autoimmune thyroiditis
0.001 0.913 0.086
L41.1 Pityriasis lichenoides chronica
0.001 0.913 0.087
E66 Obesity
0.000 0.913 0.087
L43.3 Subacute (active) lichen planus
0.000 0.918 0.082
L43.2 Lichenoid drug reaction
0.000 0.918 0.082
L43.1 Bullous lichen planus
0.000 0.918 0.082
L43.0 Hypertrophic lichen planus
0.000 0.918 0.082
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.927 0.073
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.933 0.067
L43.8 Other lichen planus
0.000 0.935 0.064
E66.1 Drug-induced obesity
0.000 0.938 0.062
E20-E35 Disorders of other endocrine glands
0.000 0.938 0.062
E78.8 Other disorders of lipoprotein metabolism
0.000 0.938 0.062
E04.2 Non-toxic multinodular goitre
0.000 0.941 0.059
E78.6 Lipoprotein deficiency
0.000 0.943 0.057
L43.9 Lichen planus, unspecified
0.000 0.943 0.057
E66.0 Obesity due to excess calories
0.000 0.947 0.053
E34 Other endocrine disorders
0.000 0.950 0.050
E78.4 Other hyperlipidaemia
0.000 0.951 0.049
E24 Cushing's syndrome
0.000 0.952 0.048
E78.3 Hyperchylomicronaemia
0.000 0.953 0.047
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.955 0.045
E32 Diseases of thymus
0.000 0.955 0.045
E31 Polyglandular dysfunction
0.000 0.955 0.045
E30 Disorders of puberty, not elsewhere classified
0.000 0.955 0.045
E78.1 Pure hyperglyceridaemia
0.000 0.956 0.044
E25 Adrenogenital disorders
0.000 0.956 0.044
E34.9 Endocrine disorder, unspecified
0.000 0.956 0.044
E20 Hypoparathyroidism
0.000 0.956 0.043
N40-N51 Diseases of male genital organs
0.042 0.958 0.000
E28 Ovarian dysfunction
0.000 0.960 0.040
N42.1 Congestion and haemorrhage of prostate
0.040 0.960 0.000
E78.2 Mixed hyperlipidaemia
0.000 0.961 0.039
N42 Other disorders of prostate
0.039 0.961 0.000
E29 Testicular dysfunction
0.000 0.963 0.037
N41 Inflammatory diseases of prostate
0.036 0.964 0.000
E34.5 Androgen resistance syndrome
0.000 0.964 0.036
E34.4 Constitutional tall stature
0.000 0.964 0.036
E34.3 Short stature, not elsewhere classified
0.000 0.964 0.036
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.964 0.036
E34.1 Other hypersecretion of intestinal hormones
0.000 0.964 0.036
E24.2 Drug-induced Cushing's syndrome
0.000 0.964 0.036
E24.9 Cushing's syndrome, unspecified
0.000 0.965 0.035
N41.9 Inflammatory disease of prostate, unspecified
0.035 0.965 0.000
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.965 0.035
E24.0 Pituitary-dependent Cushing's disease
0.000 0.965 0.035
E26 Hyperaldosteronism
0.000 0.965 0.034
E34.8 Other specified endocrine disorders
0.000 0.965 0.035
E34.0 Carcinoid syndrome
0.000 0.965 0.034
E24.8 Other Cushing's syndrome
0.000 0.965 0.034
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.965 0.034
E24.3 Ectopic ACTH syndrome
0.000 0.965 0.034
E24.1 Nelson's syndrome
0.000 0.965 0.034
E28.3 Primary ovarian failure
0.000 0.966 0.034
E30.9 Disorder of puberty, unspecified
0.000 0.968 0.032
E30.8 Other disorders of puberty
0.000 0.968 0.032
E30.1 Precocious puberty
0.000 0.968 0.032
E30.0 Delayed puberty
0.000 0.968 0.032
E31.9 Polyglandular dysfunction, unspecified
0.000 0.968 0.032
E31.8 Other polyglandular dysfunction
0.000 0.968 0.032
E31.1 Polyglandular hyperfunction
0.000 0.968 0.032
E31.0 Autoimmune polyglandular failure
0.000 0.968 0.032
E32.9 Disease of thymus, unspecified
0.000 0.968 0.032
E32.8 Other diseases of thymus
0.000 0.968 0.032
E32.1 Abscess of thymus
0.000 0.968 0.032
E32.0 Persistent hyperplasia of thymus
0.000 0.968 0.032
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.968 0.032
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.968 0.032
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.968 0.032
E25.9 Adrenogenital disorder, unspecified
0.000 0.968 0.032
E25.8 Other adrenogenital disorders
0.000 0.968 0.032
N42.0 Calculus of prostate
0.032 0.968 0.000
E27 Other disorders of adrenal gland
0.000 0.968 0.032
E20.8 Other hypoparathyroidism
0.000 0.968 0.031
E20.1 Pseudohypoparathyroidism
0.000 0.968 0.031
E20.0 Idiopathic hypoparathyroidism
0.000 0.968 0.031
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.969 0.031
E14.9 Without complications
0.000 0.969 0.031
N46 Male infertility
0.031 0.969 0.000
N44 Torsion of testis
0.031 0.969 0.000
N51 Disorders of male genital organs in diseases classified elsewhere
0.031 0.969 0.000
E20.9 Hypoparathyroidism, unspecified
0.000 0.970 0.030
E22 Hyperfunction of pituitary gland
0.000 0.970 0.030
E28.9 Ovarian dysfunction, unspecified
0.000 0.971 0.029
E28.8 Other ovarian dysfunction
0.000 0.971 0.029
E28.1 Androgen excess
0.000 0.971 0.029
E28.0 Oestrogen excess
0.000 0.971 0.029
N42.8 Other specified disorders of prostate
0.029 0.971 0.000
N42.3 Dysplasia of prostate
0.028 0.972 0.000
E87 Other disorders of fluid, electrolyte and acid-base balance
0.000 0.972 0.028
E27.1 Primary adrenocortical insufficiency
0.000 0.973 0.027
K90-K93 Other diseases of the digestive system
0.000 0.973 0.027
N49 Inflammatory disorders of male genital organs, not elsewhere classified
0.027 0.973 0.000
E29.9 Testicular dysfunction, unspecified
0.000 0.973 0.026
E29.8 Other testicular dysfunction
0.000 0.973 0.026
E29.0 Testicular hyperfunction
0.000 0.973 0.026
N41.8 Other inflammatory diseases of prostate
0.026 0.974 0.000
N41.3 Prostatocystitis
0.026 0.974 0.000
N41.2 Abscess of prostate
0.026 0.974 0.000
I71 Aortic aneurysm and dissection
0.026 0.974 0.000
E87.3 Alkalosis
0.000 0.974 0.025
L03.1 Cellulitis of other parts of limb
0.000 0.975 0.025
I71.0 Dissection of aorta [any part]
0.025 0.975 0.000
E26.8 Other hyperaldosteronism
0.000 0.975 0.025
E26.1 Secondary hyperaldosteronism
0.000 0.975 0.025
I71.2 Thoracic aortic aneurysm, without mention of rupture
0.025 0.975 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.976 0.024
I71.9 Aortic aneurysm of unspecified site, without mention of rupture
0.024 0.976 0.000
E27.8 Other specified disorders of adrenal gland
0.000 0.976 0.024
N42.2 Atrophy of prostate
0.024 0.976 0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.976 0.024
E27.2 Addisonian crisis
0.000 0.976 0.023
N41.0 Acute prostatitis
0.024 0.976 0.000
E27.5 Adrenomedullary hyperfunction
0.000 0.977 0.023
E27.0 Other adrenocortical overactivity
0.000 0.977 0.023
N45 Orchitis and epididymitis
0.023 0.977 0.000
N51.2 Balanitis in diseases classified elsewhere
0.023 0.977 0.000
N51.8 Other disorders of male genital organs in diseases classified elsewhere
0.022 0.978 0.000
N51.1 Disorders of testis and epididymis in diseases classified elsewhere
0.022 0.978 0.000
N51.0 Disorders of prostate in diseases classified elsewhere
0.022 0.978 0.000
E26.9 Hyperaldosteronism, unspecified
0.000 0.978 0.022
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.978 0.021
E22.8 Other hyperfunction of pituitary gland
0.000 0.978 0.021
I71.3 Abdominal aortic aneurysm, ruptured
0.021 0.978 0.000
N41.1 Chronic prostatitis
0.021 0.979 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.000 0.979 0.021
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture
0.021 0.979 0.000
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
0.020 0.979 0.000
E87.4 Mixed disorder of acid-base balance
0.000 0.980 0.020
E26.0 Primary hyperaldosteronism
0.000 0.980 0.020
I71.1 Thoracic aortic aneurysm, ruptured
0.019 0.980 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.981 0.019
N49.9 Inflammatory disorder of unspecified male genital organ
0.019 0.981 0.000
N49.0 Inflammatory disorders of seminal vesicle
0.019 0.981 0.000
E29.1 Testicular hypofunction
0.000 0.981 0.018
I71.8 Aortic aneurysm of unspecified site, ruptured
0.019 0.981 0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured
0.019 0.981 0.000
M06.9 Rheumatoid arthritis, unspecified
0.000 0.981 0.019
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.982 0.018
E23 Hypofunction and other disorders of pituitary gland
0.000 0.982 0.018
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.982 0.018
N49.2 Inflammatory disorders of scrotum
0.017 0.983 0.000
N49.8 Inflammatory disorders of other specified male genital organs
0.017 0.983 0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture
0.017 0.983 0.000
E66.8 Other obesity
0.000 0.984 0.016
N42.9 Disorder of prostate, unspecified
0.016 0.984 0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.984 0.016
E87.1 Hypo-osmolality and hyponatraemia
0.000 0.984 0.016
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.984 0.016
M06 Other rheumatoid arthritis
0.000 0.985 0.015
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.985 0.015
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.015 0.985 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.985 0.015
E22.1 Hyperprolactinaemia
0.001 0.985 0.014
N43 Hydrocele and spermatocele
0.015 0.985 0.000
E87.0 Hyperosmolality and hypernatraemia
0.000 0.985 0.014
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.986 0.014
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.986 0.014
K93.1 Megacolon in Chagas' disease
0.000 0.986 0.014
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.986 0.014
R60.9 Oedema, unspecified
0.000 0.986 0.014
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.986 0.014
M07.3 Other psoriatic arthropathies
0.000 0.986 0.014
E86 Volume depletion
0.000 0.987 0.013

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.